Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway. | J Transl Med | 2023 | 38012658 | PubTator, text mining | PubMed |
| Intercellular Communication in Airway Epithelial Cell Regeneration: Potential Roles of Connexins and Pannexins. | Int J Mol Sci | 2023 | 38003349 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer. | World J Clin Oncol | 2023 | 37970110 | PubTator, text mining | PubMed |
| Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. | EBioMedicine | 2023 | 37924708 | PubTator, text mining | PubMed |
| Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. | Cancer Cell Int | 2023 | 37919768 | PubTator, text mining | PubMed |
| Genetic testing in focal segmental glomerulosclerosis: in whom and when? | Clin Kidney J | 2023 | 37915894 | PubTator, text mining | PubMed |
| Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis. | Kidney Dis (Basel) | 2023 | 37900001 | PubTator, text mining | PubMed |
| Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis. | Kidney Dis (Basel) | 2023 | 37899999 | PubTator, text mining | PubMed |
| PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development. | Cancers (Basel) | 2023 | 37894409 | PubTator, text mining | PubMed |
| Pan-cancer genetic analysis of disulfidptosis-related gene set. | Cancer Genet | 2023 | 37879141 | PubTator, text mining | PubMed |
| NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. | Cell Commun Signal | 2023 | 37853467 | PubTator, text mining | PubMed |
| Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation. | Commun Biol | 2023 | 37838732 | PubTator, text mining | PubMed |
| Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence. | Int J Mol Sci | 2023 | 37833976 | PubTator, text mining | PubMed |
| Impact of the Physical Cellular Microenvironment on the Structure and Function of a Model Hepatocyte Cell Line for Drug Toxicity Applications. | Cells | 2023 | 37830622 | PubTator, text mining | PubMed |
| Deubiquitinase OTUD3: a double-edged sword in immunity and disease. | Front Cell Dev Biol | 2023 | 37829187 | PubTator, text mining | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| Analysis of G-quadruplex forming sequences in podocytes-marker genes and their potential roles in inherited glomerular diseases. | Heliyon | 2023 | 37809648 | PubTator, text mining | PubMed |
| Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis. | Front Immunol | 2023 | 37795085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=9